Literature DB >> 18556018

Molecular basis of funny current (If) in normal and failing human heart.

Francesca Stillitano1, Giuseppe Lonardo, Stephen Zicha, Andras Varro, Elisabetta Cerbai, Alessandro Mugelli, Stanley Nattel.   

Abstract

I(f) overexpression has been functionally demonstrated in ventricular myocytes from failing human hearts. Altered expression of I(f)-channels as a consequence of electrophysiological remodeling may represent an arrhythmogenic mechanism in heart failure; however, the molecular basis of I(f) overexpression in human cardiac disease is unknown. HCN1, 2 and 4 subtypes, which encode I(f)-channels, have been identified in the heart. The present study was designed to characterize HCN isoform expression in failing and non-failing hearts. Ventricular and atrial samples were obtained from normal or failing hearts explanted from patients with end-stage ischemic cardiomyopathy. I(f) was recorded in patch-clamped left ventricular myocytes. mRNA and protein expression of HCN subunits were measured in both atria and ventricles of control and diseased hearts. HCN2 and HCN4 were detected in human myocardium. Both mRNA and protein levels of HCN2/4 were significantly augmented in failing ventricles (p<0.01 for mRNA, p<0.05 for protein). These results are consistent with the electrophysiological data showing that, in failing ventricular myocytes, I(f) is of larger amplitude and activates at less negative potential. Changes in mRNA and protein expression of both HCN2/4 isoforms in atrial specimens from patients with heart failure mirrored those observed in ventricles (p<0.001 for mRNA, p<0.05 for protein). No disease-dependent alteration was detected for MiRP1, the putative beta-subunit of the I(f)-channel. In conclusion, HCN4 is the predominant channel subtype in normal human heart, and its expression is further amplified by disease. HCN upregulation likely contributes to increased I(f) and may play a role in ventricular and atrial arrhythmogenesis in heart failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556018     DOI: 10.1016/j.yjmcc.2008.04.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  59 in total

Review 1.  Exploring HCN channels as novel drug targets.

Authors:  Otilia Postea; Martin Biel
Journal:  Nat Rev Drug Discov       Date:  2011-11-18       Impact factor: 84.694

Review 2.  HCN channels in the heart: lessons from mouse mutants.

Authors:  S Herrmann; F Hofmann; J Stieber; A Ludwig
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Remodeling of the peripheral cardiac conduction system in response to pressure overload.

Authors:  Brett S Harris; Catalin F Baicu; Nicole Haghshenas; Harinath Kasiganesan; Dimitri Scholz; Mary S Rackley; Lucile Miquerol; Daniel Gros; Rupak Mukherjee; Terrence X O'Brien
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-03       Impact factor: 4.733

4.  Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression.

Authors:  S Suffredini; F Stillitano; L Comini; M Bouly; S Brogioni; C Ceconi; R Ferrari; A Mugelli; E Cerbai
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 5.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

6.  Fast and furious: new ways to think about, study and treat cardiac arrhythmias.

Authors:  Michael J Joyner; Stanley Nattel
Journal:  J Physiol       Date:  2009-04-01       Impact factor: 5.182

7.  Non-proteolytic HCN2 in the heart.

Authors:  Han-Gang Yu; Jianying Huang; Yen-Chang Lin
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

8.  Possible mechanisms of sudden cardiac death in top athletes: a basic cardiac electrophysiological point of view.

Authors:  András Varró; István Baczkó
Journal:  Pflugers Arch       Date:  2010-02-26       Impact factor: 3.657

Review 9.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

10.  Transcription profiling of HCN-channel isotypes throughout mouse cardiac development.

Authors:  Patrick A Schweizer; Pessah Yampolsky; Rizwan Malik; Dierk Thomas; Joerg Zehelein; Hugo A Katus; Michael Koenen
Journal:  Basic Res Cardiol       Date:  2009-05-07       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.